COMMUNIQUÉS West-GlobeNewswire
-
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
19/12/2025 -
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
19/12/2025 -
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
19/12/2025 -
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
19/12/2025 -
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
19/12/2025 -
Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care
19/12/2025 -
Novartis and US government reach agreement on lowering drug prices in the US
19/12/2025 -
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
19/12/2025 -
Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation
19/12/2025 -
Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
19/12/2025 -
Tevogen CEO Donates Personal Shares to Support Local Fire Department
19/12/2025 -
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
19/12/2025 -
OncoInv and MaxBloch Partner to Expand Early Cancer Detection Across Central America
19/12/2025 -
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
19/12/2025 -
Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions
19/12/2025 -
Bobby Rahal Automotive Group Donates $35,000 to SoldierStrong to Support Military Veterans in Taking Their Next Steps Forward
19/12/2025 -
European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor
19/12/2025 -
EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI’s Large Language Models (LLMs) for Research and Risk Decision Support
19/12/2025 -
Jyong Biotech Responds to Share Price and Volume Movement
19/12/2025
Pages